Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risks and Prevention of Severe Respiratory Syncytial Virus Infection among Infants and Children with Pulmonary Hypoplasia, Airway Stenosis, Congenital Esophageal Atresia, Inborn Errors of Metabolism, or Neuromuscular Diseases in Japan.
Mori M, Ito Y, Ishiwada N, Ito K, Shinjoh M, Tsugawa T, Funaki T, Furuichi M, Hoshino T, Miyairi I, Kondo T, Hinoki A, Wada M, Okada K, Korematsu S, Tanuma N, Hasegawa H, Hosoi K, Yoshizaki K, Ishige M; Working Group for ‘Guidelines for the use of palivizumab in Japan for additional indications’. Mori M, et al. J Infect Chemother. 2024 Dec 12:S1341-321X(24)00335-0. doi: 10.1016/j.jiac.2024.12.017. Online ahead of print. J Infect Chemother. 2024. PMID: 39674346 Review.
Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial.
Mori M, Yoshizaki K, Watabe S, Ishige M, Hinoki A, Kondo T, Taguchi T, Hasegawa H, Hatata T, Tanuma N, Kirino K, Hirakawa A, Naruto T, Imai M, Koike R, Hosoi K, Kusuda S. Mori M, et al. Lancet Reg Health West Pac. 2023 Jul 26;39:100847. doi: 10.1016/j.lanwpc.2023.100847. eCollection 2023 Oct. Lancet Reg Health West Pac. 2023. PMID: 37554997 Free PMC article.
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Taniguchi Y, Tamiya A, Osuga M, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Shimada M, Ando M, Koh Y. Taniguchi Y, et al. Among authors: mori m. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01500-9. Online ahead of print. Invest New Drugs. 2025. PMID: 39789369
Autonomous ribosome biogenesis in vitro.
Kosaka Y, Miyawaki Y, Mori M, Aburaya S, Nishizawa C, Chujo T, Niwa T, Miyazaki T, Sugita T, Fukuyama M, Taguchi H, Tomizawa K, Sugase K, Ueda M, Aoki W. Kosaka Y, et al. Among authors: mori m. Nat Commun. 2025 Jan 8;16(1):514. doi: 10.1038/s41467-025-55853-7. Nat Commun. 2025. PMID: 39779722 Free PMC article.
9,990 results